Check out our most popular compounded medications! Get Started
The Dantrolene Sodium 25 mg/5 mL Gastric Tube Liquid is a specially compounded medication intended for administration through a gastric tube. This formulation is designed to provide accurate dosing and safe delivery of dantrolene sodium to patients who are unable to swallow oral medications. It is most commonly utilized in hospital environments or for individuals with swallowing impairments.
Dantrolene Sodium is a muscle relaxant that works by directly affecting skeletal muscle function and decreasing muscle rigidity. It is primarily used in the treatment of malignant hyperthermia, a life-threatening complication of certain anesthetic agents, and may also be prescribed for the management of neuroleptic malignant syndrome, a rare but serious reaction to neuroleptic medications. Additionally, it is indicated for the treatment of spasticity resulting from conditions such as spinal cord injury, stroke, cerebral palsy, or multiple sclerosis.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Dantrolene Sodium 25 mg/5 mL Gastric Tube Liquid is a specialized pharmaceutical preparation tailored for administration through a gastric tube. This formulation is particularly beneficial for patients who are unable to swallow oral medications, including those with neurological or muscular disorders that impair swallowing reflexes, or for patients who are unconscious or sedated in a hospital setting. The liquid form ensures that the medication can be delivered safely and accurately, providing the necessary therapeutic effects without the need for oral ingestion.
Dantrolene Sodium, the active ingredient in this formulation, is a muscle relaxant that works by interfering with the release of calcium ions in skeletal muscle cells, thereby reducing the muscle contractions. It is primarily used in the treatment of malignant hyperthermia, a life-threatening complication of certain anesthetic agents, and in the management of neuroleptic malignant syndrome, a rare but serious reaction to neuroleptic medications. Additionally, Dantrolene Sodium has been used off-label for the treatment of muscle spasticity resulting from conditions such as spinal cord injury, cerebral palsy, and multiple sclerosis.
The 25 mg/5 mL concentration allows for precise dosing adjustments according to the patient's weight, severity of the condition, and response to the medication. The liquid formulation is prepared under strict compounding guidelines to ensure stability, sterility, and efficacy of the medication. It is important for prescribers to monitor the patient's liver function, as Dantrolene Sodium has been associated with hepatotoxicity. Regular assessment of the patient's condition and response to therapy is also recommended to adjust the dose as needed.
For patients and prescribers considering the use of Dantrolene Sodium 25 mg/5 mL Gastric Tube Liquid, it is essential to understand the specific indications, potential side effects, and the importance of accurate dosing. This formulation provides a viable option for patients with special administration needs, ensuring that they receive the full therapeutic benefits of the medication. If you have any questions or require further information about this formulation, please do not hesitate to reach out to us at Bayview Pharmacy. Our team of knowledgeable compounding pharmacists is dedicated to providing support and guidance to ensure optimal patient care.
Dantrolene Sodium is a muscle relaxant that works by affecting the flow of calcium in the muscle cells, thereby reducing the strength of the muscle contractions. It is primarily used in the treatment of malignant hyperthermia, a life-threatening condition often triggered by certain anesthetics, and in the management of chronic spasticity resulting from upper motor neuron disorders, such as cerebral palsy, stroke, spinal cord injury, or multiple sclerosis. When considering the use of Dantrolene Sodium 25 mg/5 mL Gastric Tube Liquid, it is crucial to be aware of potential drug interactions that may affect the efficacy of the treatment or increase the risk of adverse effects.
Central nervous system depressants, including alcohol, benzodiazepines, opioids, and barbiturates, can have additive effects when used concurrently with dantrolene, potentially leading to increased sedation, respiratory depression, and further suppression of central nervous system functions. Caution is advised when co-administering these agents, and dosage adjustments may be necessary. Additionally, the concomitant use of dantrolene with neuroleptic agents, such as antipsychotics, may increase the risk of developing neuroleptic malignant syndrome, a condition that shares some similarities with malignant hyperthermia and can also be life-threatening.
Patients receiving calcium channel blockers, particularly those used for the management of cardiovascular conditions, should be monitored closely when starting dantrolene therapy. The combination of these medications can lead to an increased risk of myocardial depression, ventricular fibrillation, and cardiovascular collapse. Estrogen therapy has been reported to enhance the hepatotoxic effects of dantrolene, and therefore, liver function should be monitored regularly in patients receiving both medications. Liver enzyme inducers, such as certain antiepileptics and antibiotics, may alter the metabolism of dantrolene, necessitating adjustments in dosing to maintain therapeutic effectiveness.
It is also important to consider the potential for interactions with over-the-counter medications and dietary supplements. Patients should be advised to consult with their healthcare provider before taking any new medications, including herbal supplements, while on dantrolene therapy. Regular monitoring, including liver function tests and assessments of muscle strength and neurological status, is recommended to ensure safe and appropriate use of Dantrolene Sodium 25 mg/5 mL Gastric Tube Liquid. If you have any questions or require further information regarding drug interactions with dantrolene, please reach out to us at Bayview Pharmacy for assistance.
The Dantrolene Sodium 25 mg/5 mL Gastric Tube Liquid is a specialized formulation designed to facilitate the administration of dantrolene sodium, a muscle relaxant, through a gastric tube. This delivery method is particularly beneficial for patients who are unable to swallow oral medications due to various medical conditions, such as severe neurological disorders, or those who are under intensive care and require a gastric tube for feeding and medication administration.
Dantrolene sodium, the active ingredient in this formulation, works by directly acting on skeletal muscle fibers to reduce muscle contractions. It does this by interfering with the release of calcium ions from the sarcoplasmic reticulum within the muscle cells. By inhibiting this release, dantrolene sodium diminishes the strength of the muscle contraction and helps to alleviate muscle spasticity. Additionally, dantrolene is the drug of choice for the management of malignant hyperthermia, a life-threatening complication of certain anesthetic agents characterized by rapid onset of high fever and severe muscle contractions.
The liquid formulation ensures that the medication can be accurately measured and administered in a consistent dose, which is crucial for maintaining therapeutic levels of the drug in the bloodstream. The use of a gastric tube for administration bypasses the need for swallowing and allows the medication to be delivered directly to the stomach, from where it is absorbed into the bloodstream. This method of administration is particularly useful in hospital settings or for patients with swallowing difficulties, ensuring that they receive the necessary treatment without the risk of aspiration or other complications associated with oral administration.
It is important for both patients and prescribers to understand that the effectiveness and safety of dantrolene sodium depend on proper dosing and administration. Monitoring for potential side effects, such as muscle weakness, drowsiness, and liver toxicity, is also essential. Prescribers should consider the patient's overall health status, including liver function, when determining the appropriateness of this medication. Additionally, patients or caregivers should be trained on how to administer the medication via a gastric tube to ensure proper use.
If you have any questions about the Dantrolene Sodium 25 mg/5 mL Gastric Tube Liquid formulation or its administration, please reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to provide you with the information and support you need to effectively manage your patient's condition.
This is a specifically formulated liquid medication containing 25 milligrams of Dantrolene Sodium per 5 milliliters. It is designed for administration through a gastric tube to ensure a precise and safe delivery of the medication to patients who are unable to take oral medications.
The medication should be administered directly via a gastric tube. It is important to follow the instructions provided by the healthcare professional for dosage and administration procedures to ensure safety and effectiveness.
Patients who are unable to swallow pills or tablets, those with certain neurological conditions that impair swallowing, or individuals under hospital care that require precise medication dosing can benefit from this formulation.
While commonly used in hospital settings, Dantrolene Sodium Gastric Tube Liquid may also be used at home under the direction of a healthcare professional who can provide the necessary instructions and monitoring for its safe use.
The dosage can be adjusted by a healthcare professional based on the individual's medical condition, weight, and response to treatment. It is crucial that dosing adjustments are made by a qualified healthcare provider.
If a dose is missed, it should be administered as soon as possible unless it is almost time for the next scheduled dose. In that case, the missed dose should be skipped. Do not double the dose to catch up. Consult with a healthcare professional for guidance.
This medication should be stored at room temperature, away from light and moisture. Keep the bottle tightly closed when not in use, and ensure that it is out of reach of children and pets. Always check expiration dates and do not use beyond that time.
As with any medication, there may be side effects which can include weakness, drowsiness, dizziness, nausea, or liver problems. It's important to consult a healthcare professional if any of these effects persist or worsen.
Yes, there can be drug interactions with Dantrolene Sodium. It is important to inform your healthcare provider about all medications, supplements, and herbs you are currently taking to avoid any potential interactions.
In the event of an overdose, seek immediate medical attention or call a poison control center. Signs of an overdose may include severe drowsiness, muscle weakness, or fainting, and prompt medical intervention is crucial.
Yes, this medication is available only with a doctor's prescription. Always ensure you have a valid prescription and consult your healthcare provider for any questions or concerns regarding the usage of this medication.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
